ProQR Therapeutics N.V.

Healthcare

NASDAQ:PRQR · NASDAQ Global Market

Market Cap $199.13M Beta 0.06 P/E (TTM) -3.8

$1.89 +12.28%

+$0.21 today

52W Low $1.33High $3.10

Vol 1.10M · Avg 0.62M

EPS (TTM) -$0.43Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-3.08%

Period High

$3.05

Period Low

$1.37

Latest

$1.89

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Capricor Therapeutics, Inc.

NASDAQ:CAPR

$1.31B

Achieve Life Sciences, Inc.

NASDAQ:ACHV

$505.60M

Allogene Therapeutics, Inc.

NASDAQ:ALLO

$490.18M

Vanda Pharmaceuticals Inc.

NASDAQ:VNDA

$349.53M

Entrada Therapeutics, Inc.

NASDAQ:TRDA

$267.47M

Editas Medicine, Inc.

NASDAQ:EDIT

$257.97M

Zura Bio Limited

NASDAQ:ZURA

$241.88M

Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

$213.17M

Immutep Limited

NASDAQ:IMMP

$55.46M

Mereo BioPharma Group plc

NASDAQ:MREO

$51.40M

What is the latest PRQR filing?

The latest filing shown is SC 13D/A dated Jun 3, 2026.

How many recent filings does PRQR have?

Intrinsic Alpha currently shows 20 recent filings for PRQR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.